MR编号 | SE/H/2455/001 |
---|
药品名称 | Icalziss |
---|
活性成分 | - Calcium chloride 340.0 mmol/l
|
---|
剂型 | Solution for infusion |
---|
上市许可持有人 | Vantive Belgium SRL
Boulevard d’Angleterre 2
1420 Braine-l’Alleud
Belgium |
---|
参考成员国 - 产品名称 | Sweden (SE) Icalziss |
---|
互认成员国 - 产品名称 | - Denmark (DK)
Icalziss - Norway (NO)
- Slovenia (SI)
- Belgium (BE)
Icalziss 340 mmol/l solution pour perfusion - Finland (FI)
- Malta (MT)
- Netherlands (NL)
Icalziss 340 mmol/L oplossing voor infusie - Poland (PL)
- Croatia (HR)
- Luxembourg (LU)
- Latvia (LV)
- Iceland (IS)
- Lithuania (LT)
- Ireland (IE)
- Estonia (EE)
- Austria (AT)
- Hungary (HU)
Calryplaze 340 mmol/l oldatos infúzió - France (FR)
- Bulgaria (BG)
Calryplaze 340mmol/l solution for infusion - Spain (ES)
- Cyprus (CY)
CALRYPLAZE 340 mmol/L Διάλυμα για έγχυση - Portugal (PT)
- Czechia (CZ)
CALRYPLAZE 340 mmol/L Infuzní Roztok - Italy (IT)
- Romania (RO)
CALRYPLAZE 340 mmol/L Soluţie Perfuzabilă - Germany (DE)
CALRYPLAZE 340 mmol/L Infusionslösung - Greece (GR)
- Slovakia (SK)
|
---|
许可日期 | 2024/10/04 |
---|
最近更新日期 | 2025/01/07 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|